Life Sciences

Dibrugarh University, the easternmost University of India was set up in 1965 under the provisions of the Dibrugarh University Act, 1965 enacted by the Assam Legislative Assembly. It is a teaching-cum-affiliating University with limited residential facilities. The University is situated at Rajabheta at a distance of about five kilometres to the south of the premier town of Dibrugarh in the eastern part of Assam as well as India.

Traineeship  01 (one post) purely temporary for a period of five month.

CSIR - IHBT is the only laboratory of the Council of Scientific and Industrial Research in the State of Himachal Pradesh (H.P.), India. Institute has a focused research mandate on bioresources for catalysizing bioeconomy in a sustainable manner. The institute has:  state-of the art laboratories; remote sensing and mapping facilities; internationally recognised herbarium; animal house facility; pilot plants in nutraceuticals, essential oil and herbals; farms and polyhouses.

Post : Research Associate-I OR Research Associate-II OR Research Associate-III

Biocon is a research-driven, global healthcare company with a strong matrix of capabilities along the biopharmaceutical value chain. Focusing on unmet medical needs in cancer, diabetes and inflammatory diseases, it offers novel therapies on a platform of affordable innovation. Biocon together with group companies employs more than 2500 employees with approxmimately Rs 1,000 crore turnover and is expected to grow further during the current financial year.

Institute of Nano Science and Technology (INST), Mohali (Punjab), an autonomous institution of Department of Science and Technology (DST), Government of India, has been established under the umbrella of NANO MISSION, initiated by DST to boost research and development in the field of Nanoscience and Nanotechnology in India. INST started its activities on 3rd January 2013, the date on which its first Director was appointed. The institute is currently operating from its transit campus at Habitat Centre, Sector-64, Phase-X, Mohali, Punjab.

Online Applications are invited from highly motivated and bright candidates for the position of JRF in research project at Institute of Nano Science and Technology, Mohali.

Post : Junior Research Fellow

Translational Health Science and Technology Institute (THSTI) is an autonomous Institute of the Department of Biotechnology, Ministry of Science and Technology, Govt, of India.

Clinical Development Services Agency (CDSA) is an extramural unit of Translational Health Science and Technology Institute (THSTI) and has been established as a not-for-profit society to provide cost affective, high quality preclinical and clinical product development support services to meet the country’s growing healthcare needs. It will tend enterprises; particularly SMEs involved in new technology innovation and facilitate translation of scientific know-how into viable products.

Institute of Nano Science and Technology (INST), Mohali (Punjab), an autonomous institution of Department of Science and Technology (DST), Government of India, has been established under the umbrella of NANO MISSION, initiated by DST to boost research and development in the field of Nanoscience and Nanotechnology in India. INST started its activities on 3rd January 2013, the date on which its first Director was appointed. The institute is currently operating from its transit campus at Habitat Centre, Sector-64, Phase-X, Mohali, Punjab.

Highly motivated and bright candidates are required for the position of Project Junior Research Fellow (JRF) in the research project funded by ‘DBT’.

Post : Junior Research Fellow (JRF)

The legacy of Alembic Pharmaceuticals Limited (APL) dates back to over 100 years. Established in 1907 with an objective to develop and revolutionize the Pharmaceutical and Drug industry in the Indian subcontinent, Alembic Pharmaceuticals Limited today is one of the leading pharmaceutical companies in India.

Post : Medical Representative

Novo Nordisk is a global healthcare company with 89 years of innovation and leadership in diabetes care. The company also has leading positions within Haemophilia care, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 33,300 employees in 75 countries, and markets its products in more than 190 countries Novo Nordisk’s B shares are listed on NASDAQ OMX Copenhagen (Novo-B).